Warfarin sodium and Bone neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Bone neoplasm malignant is reported as a side effect among people who take Warfarin sodium (warfarin sodium), especially for people who are male, 50-59 old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Bone neoplasm malignant when taking Warfarin sodium. It is created by eHealthMe based on reports of 67,331 people who have side effects when taking Warfarin sodium from the FDA, and is updated regularly.

What is Warfarin sodium?

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 71,174 Warfarin sodium users. Check the latest studies of Warfarin sodium.

What is Bone neoplasm malignant?

Bone neoplasm malignant (cancer of bone) is found to be associated with 292 drugs and 214 conditions by eHealthMe. Check the latest studies of Bone neoplasm malignant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

67,331 people reported to have side effects when taking Warfarin sodium.
Among them, 33 people (0.05%) have Bone neoplasm malignant.

Could Warfarin sodium cause Bone neoplasm malignant?

Among these 33 people:

What is the gender of people who have Bone neoplasm malignant when taking Warfarin sodium? *

female: 39.39 %
male: 60.61 %

What is the age of people who have Bone neoplasm malignant when taking Warfarin sodium? *

What are other drugs people take besides Warfarin sodium? *

What are other side effects people have besides Bone neoplasm malignant? *

Pain: 25 people, 75.76%
Dyspnea (difficult or laboured breathing): 22 people, 66.67%
Depression: 22 people, 66.67%
Multiple Myeloma (cancer of the plasma cells): 22 people, 66.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 21 people, 63.64%
Fatigue (feeling of tiredness): 21 people, 63.64%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 20 people, 60.61%
Osteonecrosis Of Jaw (death of bone of jaw): 19 people, 57.58%
Stress And Anxiety: 19 people, 57.58%
Hypotension (abnormally low blood pressure): 19 people, 57.58%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 6 people, 18.18%
High Blood Cholesterol: 5 people, 15.15%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 15.15%
Bone Disorder: 5 people, 15.15%
Urination - Painful: 2 people, 6.06%
Enlarged Prostate: 2 people, 6.06%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 3.03%
Stress And Anxiety: 1 person, 3.03%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 3.03%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Warfarin sodium and have Bone neoplasm malignant?

- Check whether Bone neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Warfarin sodium:

Warfarin sodium (71,174 reports)

Browse all side effects of Warfarin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone neoplasm malignant:

Bone neoplasm malignant (292 drugs)

Browse all the conditions that are associated with Bone neoplasm malignant:

Bone neoplasm malignant (214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium (the active ingredients of Warfarin sodium) and Warfarin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.